Life Sciences

Harvard Bioscience, a Holliston-based biotech firm, has fallen out of compliance with Nasdaq stock exchange requirements following the resignation of a board of directors member.

The firm is expanding its facility in Devens after designating the site as the company’s headquarters in March.

Three Central Massachusetts companies have been named among the best public companies to work for by the U.S. News & World Report.

Three Central Massachusetts companies have split more than $2 million in tax incentives as part of a broader state initiative to create new life sciences industry jobs across the commonwealth. 

Startups have navigated the perilous Valley of Death period with varying levels of success. Conifer Life Sciences Group at MBI is trying to change that.

Loewald’s departure comes after the CFO of the company resigned in May, after it reported a net loss of $12.4 million from fiscal 2024.

Mere weeks after making an unsolicited bid to buy Marlborough-based biotech firm Akoya Biosciences, the anonymous party has withdrawn its offer . 

Two months after its CFO abruptly resigned, Arch Therapeutics, a Framingham-based biotechnology company, has filed for Chapter 11 bankruptcy.

Milford-based Waters Corp. has acquired Halo Labs, a California-based company, which creates specialized imaging technology to detect interfering particles in therapeutic products.

After biotech firm Akoya Biosciences previously announced it would be acquired by Quanterix, the company is now considering an unsolicited, all-cash buyout offer it received from an anonymous third party.